Are current psychiatric treatments addressing the epidemic levels of mental illness across the world?
Where do psychiatric treatments fall short?
What does emerging research say about psychedelic therapy?
Can it fill the holes in modern treatment?
How does psychedelic therapy address PTSD, depression, and addiction?
Manny's is excited to host leading experts in psychedelic therapy, Joe Green and Amy Emerson, to help us answer all the questions we have about the research and future of mental illness and its treatment.
The structure of this event will be about 45 minutes of discussion with Joe Green and Amy Emerson followed by an audience Q&A. We hope to help solicit a more collaborative discussion and hear the diverse stories in our city.
Manny's never turns away anyone for lack of funds. To receive a complimentary ticket just email the word "grapefruit" and the title of this event [email protected].
This event will be in person at Manny's but there will also be a Zoom link ticket for those who'd like to tune in digitally from the comfort of their home. Please note that this event will be recorded.
In-person attendees MUST provide proof of COVID-19 vaccination. Go to https://myvaccinerecord.cdph.ca.gov/ to acquire a digital vaccine record.
About Joe Green:
Co-founder and President, Psychedelic Science Funders Collaborative
Joe Green is the co-founder and President of the Psychedelic Science Funders Collaborative (PSFC), a community of philanthropists that supports research on and clinical trials of psychedelic medicines, as well as patient access to these treatments. PSFC was born in 2017 out of a realization that psychedelic medicine has the potential to make an enormous impact and has an achievable path to regulatory approval, but has been systemically underfunded. In 2020, PSFC completed a $30 million fundraising campaign in partnership with the Multidisciplinary Association for Psychedelic Studies (MAPS) to support the completion of phase 3 clinical trials of MDMA-assisted psychotherapy. Joe serves on the Board of Directors of MAPS.
In addition to his work with PSFC, Joe is the chairman and co-founder of Treehouse, which builds co-living communities in Los Angeles. Treehouse's mission is to create homes that foster authentic connection and supportive relationships.
Joe is a social entrepreneur who has spent his career addressing significant challenges by marrying technology with community organizing. Joe co-founded Causes, which empowered more than 100 million people to make an impact; NationBuilder, a leading software provider for organizers; and FWD.us, which has mobilized the tech community around immigration and criminal justice reform.
About Amy Emerson:
Amy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit organization. As the Chief Executive Officer, Amy has led the growth and development of this new subsidiary and is responsible for overall global regulatory strategy and implementation of research programs with a focus on the MDMA-assisted psychotherapy program within MAPS PBC.
Amy started as a pro bono consultant at MAPS in 2003, and since then has built MAPS' clinical department while managing the MDMA Clinical Development Program with a focus on the PTSD indication. In 2014, MAPS Public Benefit Corporation was incorporated to focus on psychedelic drug development, therapist training programs, and future sales of prescription psychedelics prioritizing public benefit above profit.
Amy brings decades of pharmaceutical development and research experience in Phase 1 through Phase 3 Randomized Controlled Trials including supporting three successful regulatory approvals for new biologics. Her professional experience at Novartis, Chiron, and other pharmaceutical companies (1993-2009) spans various fields including immunology, oncology, and vaccines. Pursuing her love of science and nature cultivated while growing up in the woods of Alaska she earned her B.S. in genetics and cell biology from Washington State University in 1992 to prepare for a career in research. Amy is passionate about being a mother and the work of bringing the potential of psychedelics for healing further into the consciousness of the world, leaving a better world for the following generations. She has a lifelong love of travel, living abroad with her husband, exploring in nature, and cooking with her family.
Illustration: Frieda Ruh/The Guardian
show less
Where do psychiatric treatments fall short?
What does emerging research say about psychedelic therapy?
Can it fill the holes in modern treatment?
How does psychedelic therapy address PTSD, depression, and addiction?
Manny's is excited to host leading experts in psychedelic therapy, Joe Green and Amy Emerson, to help us answer all the questions we have about the research and future of mental illness and its treatment.
The structure of this event will be about 45 minutes of discussion with Joe Green and Amy Emerson followed by an audience Q&A. We hope to help solicit a more collaborative discussion and hear the diverse stories in our city.
Manny's never turns away anyone for lack of funds. To receive a complimentary ticket just email the word "grapefruit" and the title of this event [email protected].
This event will be in person at Manny's but there will also be a Zoom link ticket for those who'd like to tune in digitally from the comfort of their home. Please note that this event will be recorded.
In-person attendees MUST provide proof of COVID-19 vaccination. Go to https://myvaccinerecord.cdph.ca.gov/ to acquire a digital vaccine record.
About Joe Green:
Co-founder and President, Psychedelic Science Funders Collaborative
Joe Green is the co-founder and President of the Psychedelic Science Funders Collaborative (PSFC), a community of philanthropists that supports research on and clinical trials of psychedelic medicines, as well as patient access to these treatments. PSFC was born in 2017 out of a realization that psychedelic medicine has the potential to make an enormous impact and has an achievable path to regulatory approval, but has been systemically underfunded. In 2020, PSFC completed a $30 million fundraising campaign in partnership with the Multidisciplinary Association for Psychedelic Studies (MAPS) to support the completion of phase 3 clinical trials of MDMA-assisted psychotherapy. Joe serves on the Board of Directors of MAPS.
In addition to his work with PSFC, Joe is the chairman and co-founder of Treehouse, which builds co-living communities in Los Angeles. Treehouse's mission is to create homes that foster authentic connection and supportive relationships.
Joe is a social entrepreneur who has spent his career addressing significant challenges by marrying technology with community organizing. Joe co-founded Causes, which empowered more than 100 million people to make an impact; NationBuilder, a leading software provider for organizers; and FWD.us, which has mobilized the tech community around immigration and criminal justice reform.
About Amy Emerson:
Amy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit organization. As the Chief Executive Officer, Amy has led the growth and development of this new subsidiary and is responsible for overall global regulatory strategy and implementation of research programs with a focus on the MDMA-assisted psychotherapy program within MAPS PBC.
Amy started as a pro bono consultant at MAPS in 2003, and since then has built MAPS' clinical department while managing the MDMA Clinical Development Program with a focus on the PTSD indication. In 2014, MAPS Public Benefit Corporation was incorporated to focus on psychedelic drug development, therapist training programs, and future sales of prescription psychedelics prioritizing public benefit above profit.
Amy brings decades of pharmaceutical development and research experience in Phase 1 through Phase 3 Randomized Controlled Trials including supporting three successful regulatory approvals for new biologics. Her professional experience at Novartis, Chiron, and other pharmaceutical companies (1993-2009) spans various fields including immunology, oncology, and vaccines. Pursuing her love of science and nature cultivated while growing up in the woods of Alaska she earned her B.S. in genetics and cell biology from Washington State University in 1992 to prepare for a career in research. Amy is passionate about being a mother and the work of bringing the potential of psychedelics for healing further into the consciousness of the world, leaving a better world for the following generations. She has a lifelong love of travel, living abroad with her husband, exploring in nature, and cooking with her family.
Illustration: Frieda Ruh/The Guardian
Are current psychiatric treatments addressing the epidemic levels of mental illness across the world?
Where do psychiatric treatments fall short?
What does emerging research say about psychedelic therapy?
Can it fill the holes in modern treatment?
How does psychedelic therapy address PTSD, depression, and addiction?
Manny's is excited to host leading experts in psychedelic therapy, Joe Green and Amy Emerson, to help us answer all the questions we have about the research and future of mental illness and its treatment.
The structure of this event will be about 45 minutes of discussion with Joe Green and Amy Emerson followed by an audience Q&A. We hope to help solicit a more collaborative discussion and hear the diverse stories in our city.
Manny's never turns away anyone for lack of funds. To receive a complimentary ticket just email the word "grapefruit" and the title of this event [email protected].
This event will be in person at Manny's but there will also be a Zoom link ticket for those who'd like to tune in digitally from the comfort of their home. Please note that this event will be recorded.
In-person attendees MUST provide proof of COVID-19 vaccination. Go to https://myvaccinerecord.cdph.ca.gov/ to acquire a digital vaccine record.
About Joe Green:
Co-founder and President, Psychedelic Science Funders Collaborative
Joe Green is the co-founder and President of the Psychedelic Science Funders Collaborative (PSFC), a community of philanthropists that supports research on and clinical trials of psychedelic medicines, as well as patient access to these treatments. PSFC was born in 2017 out of a realization that psychedelic medicine has the potential to make an enormous impact and has an achievable path to regulatory approval, but has been systemically underfunded. In 2020, PSFC completed a $30 million fundraising campaign in partnership with the Multidisciplinary Association for Psychedelic Studies (MAPS) to support the completion of phase 3 clinical trials of MDMA-assisted psychotherapy. Joe serves on the Board of Directors of MAPS.
In addition to his work with PSFC, Joe is the chairman and co-founder of Treehouse, which builds co-living communities in Los Angeles. Treehouse's mission is to create homes that foster authentic connection and supportive relationships.
Joe is a social entrepreneur who has spent his career addressing significant challenges by marrying technology with community organizing. Joe co-founded Causes, which empowered more than 100 million people to make an impact; NationBuilder, a leading software provider for organizers; and FWD.us, which has mobilized the tech community around immigration and criminal justice reform.
About Amy Emerson:
Amy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit organization. As the Chief Executive Officer, Amy has led the growth and development of this new subsidiary and is responsible for overall global regulatory strategy and implementation of research programs with a focus on the MDMA-assisted psychotherapy program within MAPS PBC.
Amy started as a pro bono consultant at MAPS in 2003, and since then has built MAPS' clinical department while managing the MDMA Clinical Development Program with a focus on the PTSD indication. In 2014, MAPS Public Benefit Corporation was incorporated to focus on psychedelic drug development, therapist training programs, and future sales of prescription psychedelics prioritizing public benefit above profit.
Amy brings decades of pharmaceutical development and research experience in Phase 1 through Phase 3 Randomized Controlled Trials including supporting three successful regulatory approvals for new biologics. Her professional experience at Novartis, Chiron, and other pharmaceutical companies (1993-2009) spans various fields including immunology, oncology, and vaccines. Pursuing her love of science and nature cultivated while growing up in the woods of Alaska she earned her B.S. in genetics and cell biology from Washington State University in 1992 to prepare for a career in research. Amy is passionate about being a mother and the work of bringing the potential of psychedelics for healing further into the consciousness of the world, leaving a better world for the following generations. She has a lifelong love of travel, living abroad with her husband, exploring in nature, and cooking with her family.
Illustration: Frieda Ruh/The Guardian
read more
Where do psychiatric treatments fall short?
What does emerging research say about psychedelic therapy?
Can it fill the holes in modern treatment?
How does psychedelic therapy address PTSD, depression, and addiction?
Manny's is excited to host leading experts in psychedelic therapy, Joe Green and Amy Emerson, to help us answer all the questions we have about the research and future of mental illness and its treatment.
The structure of this event will be about 45 minutes of discussion with Joe Green and Amy Emerson followed by an audience Q&A. We hope to help solicit a more collaborative discussion and hear the diverse stories in our city.
Manny's never turns away anyone for lack of funds. To receive a complimentary ticket just email the word "grapefruit" and the title of this event [email protected].
This event will be in person at Manny's but there will also be a Zoom link ticket for those who'd like to tune in digitally from the comfort of their home. Please note that this event will be recorded.
In-person attendees MUST provide proof of COVID-19 vaccination. Go to https://myvaccinerecord.cdph.ca.gov/ to acquire a digital vaccine record.
About Joe Green:
Co-founder and President, Psychedelic Science Funders Collaborative
Joe Green is the co-founder and President of the Psychedelic Science Funders Collaborative (PSFC), a community of philanthropists that supports research on and clinical trials of psychedelic medicines, as well as patient access to these treatments. PSFC was born in 2017 out of a realization that psychedelic medicine has the potential to make an enormous impact and has an achievable path to regulatory approval, but has been systemically underfunded. In 2020, PSFC completed a $30 million fundraising campaign in partnership with the Multidisciplinary Association for Psychedelic Studies (MAPS) to support the completion of phase 3 clinical trials of MDMA-assisted psychotherapy. Joe serves on the Board of Directors of MAPS.
In addition to his work with PSFC, Joe is the chairman and co-founder of Treehouse, which builds co-living communities in Los Angeles. Treehouse's mission is to create homes that foster authentic connection and supportive relationships.
Joe is a social entrepreneur who has spent his career addressing significant challenges by marrying technology with community organizing. Joe co-founded Causes, which empowered more than 100 million people to make an impact; NationBuilder, a leading software provider for organizers; and FWD.us, which has mobilized the tech community around immigration and criminal justice reform.
About Amy Emerson:
Amy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit organization. As the Chief Executive Officer, Amy has led the growth and development of this new subsidiary and is responsible for overall global regulatory strategy and implementation of research programs with a focus on the MDMA-assisted psychotherapy program within MAPS PBC.
Amy started as a pro bono consultant at MAPS in 2003, and since then has built MAPS' clinical department while managing the MDMA Clinical Development Program with a focus on the PTSD indication. In 2014, MAPS Public Benefit Corporation was incorporated to focus on psychedelic drug development, therapist training programs, and future sales of prescription psychedelics prioritizing public benefit above profit.
Amy brings decades of pharmaceutical development and research experience in Phase 1 through Phase 3 Randomized Controlled Trials including supporting three successful regulatory approvals for new biologics. Her professional experience at Novartis, Chiron, and other pharmaceutical companies (1993-2009) spans various fields including immunology, oncology, and vaccines. Pursuing her love of science and nature cultivated while growing up in the woods of Alaska she earned her B.S. in genetics and cell biology from Washington State University in 1992 to prepare for a career in research. Amy is passionate about being a mother and the work of bringing the potential of psychedelics for healing further into the consciousness of the world, leaving a better world for the following generations. She has a lifelong love of travel, living abroad with her husband, exploring in nature, and cooking with her family.
Illustration: Frieda Ruh/The Guardian
show less
Date/Times:
Manny's
27 Upcoming Events
3092 16th Street, San Francisco, CA 94103
The Best Events
Every Week in Your Inbox
From Our Sponsors
UPCOMING EVENTS
Great suggestion! We'll be in touch.
Event reviewed successfully.